Andrew Lo

Insider Reports History

Entity
Individual
Location
C/O Alphasimplex Group, Llc, One Cambridge Center, 9 Th Floor, Cambridge, MA
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Lo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Roivant Sciences Ltd. Director Common Shares 52.1K $540K $10.35 Sep 15, 2022 Direct
AbCellera Biologics Inc. Director Share option (right to buy) 302K Jun 21, 2024 Direct
Roivant Sciences Ltd. Director Stock Option (Right to Buy) 71.9K Sep 15, 2022 Direct
BridgeBio Pharma, Inc. Director Stock Option (Right to Buy) 26K Jun 21, 2024 Direct

Insider Reports Filed by Andrew Lo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBIO BridgeBio Pharma, Inc. Jun 21, 2024 1 $0 4 Jun 25, 2024 Director
ABCL AbCellera Biologics Inc. Jun 21, 2024 1 $0 4 Jun 24, 2024 Director
BBIO BridgeBio Pharma, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
ABCL AbCellera Biologics Inc. Dec 1, 2022 1 $0 4 Dec 5, 2022 Director
ROIV Roivant Sciences Ltd. Sep 15, 2022 2 $0 4 Sep 19, 2022 Director
BBIO BridgeBio Pharma, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
BBIO BridgeBio Pharma, Inc. Dec 29, 2021 2 $98.9K 4 Jan 3, 2022 Director
ABCL AbCellera Biologics Inc. Dec 3, 2021 1 $0 4/A Dec 10, 2021 Director
ABCL AbCellera Biologics Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Director
ROIV Roivant Sciences Ltd. Oct 1, 2021 0 $0 3 Oct 1, 2021 Director
BBIO BridgeBio Pharma, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director